12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several health care stocks experienced significant movements. Gainers included Reata Pharmaceuticals (RETA), Homology Medicines (FIXX), Bluejay Diagnostics (BJDX), Gracell Biotechnologies (GRCL), Pulse Biosciences (PLSE), and Larimar Therapeutics (LRMR). Losers included Tonix Pharmaceuticals (TNXP), Mallinckrodt (MNK), Intelligent Bio Solutions (INBS), G Medical Innovations (GMVD), Femasys (FEMY), and Marker Therapeutics (MRKR).
July 28, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Femasys stock declined by 19.04% to $0.68.
The significant decline in Femasys' stock price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
G Medical Innovations stock declined by 19.07% to $0.28.
The substantial decline in G Medical Innovations' stock price suggests negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Intelligent Bio Solutions shares fell 19.44% to $1.91.
The significant fall in Intelligent Bio Solutions' share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Mallinckrodt stock fell 21.6% to $1.27.
The substantial fall in Mallinckrodt's stock price suggests negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Marker Therapeutics shares fell 17.2% to $6.89.
The substantial fall in Marker Therapeutics' share price suggests negative market sentiment, potentially leading to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Tonix Pharmaceuticals shares decreased by 41.0% to $1.05.
The significant decrease in Tonix Pharmaceuticals' share price indicates negative market sentiment, which could lead to further short-term losses.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Bluejay Diagnostics stock increased by 32.52% to $7.09.
The significant increase in Bluejay Diagnostics' stock price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Homology Medicines shares rose 37.22% to $1.29.
The substantial rise in Homology Medicines' share price suggests positive market sentiment, potentially leading to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Gracell Biotechnologies shares increased by 26.16% to $4.05.
The substantial increase in Gracell Biotechnologies' share price suggests positive market sentiment, potentially leading to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Larimar Therapeutics shares rose 21.54% to $3.78.
The substantial rise in Larimar Therapeutics' share price suggests positive market sentiment, potentially leading to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Pulse Biosciences shares increased by 21.79% to $8.46.
The significant increase in Pulse Biosciences' share price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Reata Pharmaceuticals shares moved upwards by 52.1% to $165.09.
The significant increase in Reata Pharmaceuticals' share price indicates positive market sentiment, which could lead to further short-term gains.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100